# APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS.

> **NCT02323724** · — · COMPLETED · sponsor: **Corporacion Parc Tauli** · enrollment: 25 (estimated)

## Conditions studied

- Papillary Thyroid Carcinoma

## Interventions

- **GENETIC:** BRAF V600E mutation by pyrosequencing technique

## Key facts

- **NCT ID:** NCT02323724
- **Lead sponsor:** Corporacion Parc Tauli
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2016-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02323724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02323724, "APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02323724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*